LX Ventures Inc.
TSX VENTURE : LXV

LX Ventures Inc.

October 30, 2013 08:00 ET

LX Ventures Portfolio Company Sosido Adds Two More Medical Associations Secured by Multi-Year Grants

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 30, 2013) - LX Ventures Inc. (TSX VENTURE:LXV) ("LXV" or the "Company") and Sosido Networks Inc. ("Sosido") are pleased to announce that the Canadian Association of Nurses in Oncology ("CANO") and the Canadian Association of General Practitioners in Oncology ("CAGPO") have launched on Sosido's platform. This expansion marks a 113% increase in users on the Sosido network, which already included the Canadian Blood and Marrow Transplant Group (CBMTG) and the Canadian Association of Pharmacy in Oncology (CAPhO) bringing the number of supported associations to four.

CBMTG, CAPhO, CANO and CAGPO have been supported to participate in the Sosido network through multi-year unrestricted grants from Hoffmann-La Roche Limited ("Roche"). Roche is a leader in the research and development of pharmaceutical and diagnostic solutions that look beyond today's horizons and make a profound difference in people's lives. Roche partners with the oncology community to support innovative services that will ultimately help healthcare professionals help their patients.

CANO is the national organization that supports Canadian nurses to promote and develop excellence in oncology nursing practice, education, research and leadership, with a mission to lead nursing excellence in cancer control for Canadians. CAGPO is the national organization that connects and promotes General Practitioners in Oncology in cancer centres and primary care settings across Canada.

Through the Sosido network members are provided a new online and mobile platform which streams the latest articles from their chosen journal feeds or knowledge sources, provides instant updates on publications by their colleagues, and facilitates discussion around clinical practice-related issues.

"We are very excited that CANO and CAGPO have chosen the Sosido solution. We're seeing significant and rapid growth in our flagship market, the Canadian hematology and oncology community, which bodes well for our objective of connecting the broader global healthcare community," said Mike Edwards, CEO of LX Ventures.

Tanis Steward, Founder and CEO of Sosido, said, "The oncology nurses and oncology general practitioners are critical to the delivery of cancer care in Canada and hold vital clinical knowledge and experience. Sosido's goal is to move that knowledge quickly from those who have it, to those who need it, resulting in better care for all patients. We're delighted that our growing community of healthcare professionals, and industry supporters like Roche, share our vision."

About LX Ventures

LX Ventures is a publicly traded technology accelerator that acquires, integrates and accelerates high growth technology companies. We are vertically integrated with internal best-in-class practice area teams in sales, marketing, engineering and finance that are leveraged to turn our portfolio companies into industry leading organizations, one by one. We are in the business of building businesses. For further information about LX Ventures, please visit: www.lxventures.com.

About Sosido Networks Inc.

Sosido is an online knowledge exchange community for physicians, nurses, pharmacists and other healthcare professionals. It uses innovative technology to connect and filter knowledge through trusted colleagues, creating a unique communication platform that revolutionizes the way health care professionals share information and collaborate with each other. The company is headquartered in Vancouver, British Columbia. To learn more, please visit www.sosido.com.

ON BEHALF OF THE BOARD

LX VENTURES INC.

Mike Edwards, CEO

CAUTIONARY NOTE: FORWARD-LOOKING STATEMENTS. Other than statements of historical fact, all statements included in this news release, including, without limitation, statements regarding future plans and objectives of LX are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Factors that could cause actual results to differ materially from those expected by LX are those risks described herein and from time to time, in the filings made by LX with Canadian securities regulators. Those filings can be found on the Internet at: http://www.sedar.com.

Neither the TSX Venture Exchange nor its Regulatory Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information